AI Article Synopsis

  • Depression is common in heart failure patients and those who undergo heart transplants, with 35.1% experiencing pre-transplant depression and 26.3% post-transplant depression.
  • Patients with post-transplant depression faced more complications, such as higher rates of acute rejection and longer hospital stays, alongside increased 5-year mortality rates (30% vs 9.5%).
  • After adjusting for other serious health factors, the impact of post-transplant depression on mortality was not statistically significant, underscoring the need for awareness and management of depression in heart transplant patients.

Article Abstract

Background: Depression is prevalent in patients with heart failure and after heart transplant. We identified the prevalence of pre- and post-transplant depression and its association with clinical characteristics and post-transplant outcomes.

Methods: We reviewed 114 adults transplanted 1/1/2015 to 12/31/2015 and identified patients with pre- and post-transplant depression. Clinical characteristics and outcomes were compared.

Results: Of 114 patients, 35.1% had pre-transplant depression and 26.3% had post-transplant depression. Patients with post-transplant depression within the first year were significantly more likely to have acute rejection (10% vs 0%), longer intensive care unit (11.7 days vs 7.8 days) and hospital stay (31.7 days vs 16.3 days), and discharge to inpatient rehabilitation (26.7% vs 8.3%). Patients with post-transplant depression within the first year had significantly higher 5-year mortality (30% vs 9.5%, p = .009). However, after adjustment for total artificial heart/biventricular assist device, acute rejection, intensive care unit, and hospital length of stay, this relationship was no longer significant (HR 2.11; 95% CI 0.18-25.27; p = .556).

Conclusions: Depression is common among heart transplant candidates and recipients. While pre-transplant depression did not impact outcomes, patients with post-transplant depression were more likely to have had a complicated course, suggesting the need for increased vigilance regarding depression in such patients.

Download full-text PDF

Source
http://dx.doi.org/10.1111/ctr.14204DOI Listing

Publication Analysis

Top Keywords

post-transplant depression
24
heart transplant
12
patients post-transplant
12
depression
11
pre- post-transplant
8
clinical characteristics
8
pre-transplant depression
8
depression patients
8
depression year
8
acute rejection
8

Similar Publications

Ventricular assist device (VAD) and cardiac transplant patients experience significant strain on their physical and mental wellbeing postoperatively. Mental health and substance use disorders (MHDs and SUDs) have substantial effects on the quality of life and compliance of transplant and VAD patients. In this study, we compare and characterize MHDs and SUDs between VAD and cardiac allograft patients and transplant list patients with and without VADs.

View Article and Find Full Text PDF

Background: Liver transplantation (LT) improves survival in end-stage liver disease. Several reports have addressed the impact of LT on patients' lives, beyond purely medical outcomes. Although the quality of life and mental health have been demonstrated to improve with this procedure, such studies are still missing in Latin America.

View Article and Find Full Text PDF

Background: Hematopoietic stem cell transplantation (HCT) is a potentially life-saving therapy for individuals with blood diseases, but involves a challenging recovery process that requires dedicated caregivers. The complex interplay between emotional distress, care partner (or unpaid caregiver) burden, and treatment outcomes necessitates comprehensive physiological and psychological measurements to fully understand these dynamics.

Findings: We collected longitudinal data from 166 HCT caregiver-patient dyads over 120 days post-transplant as part of a randomized controlled trial ( NCT04094844 ).

View Article and Find Full Text PDF
Article Synopsis
  • The study explored psychological factors related to post-traumatic stress disorder (PTSD) in liver transplant patients one year after surgery, finding limited previous evidence on this topic.
  • Data from 184 patients were analyzed, revealing a PTSD prevalence rate of 22.83% and significant correlations between PTSD symptoms and factors like pain (VAS), anxiety and depression (HADS), and psychological resilience (CD-RISC).
  • The findings indicated that higher levels of pain and anxiety/depression are risk factors for PTSD, while greater resilience serves as a protective factor, emphasizing the need for psychological support in post-transplant care.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates how positive psychological well-being (PPWB) relates to mood and quality of life in people who have undergone hematopoietic stem cell transplantation (HSCT), using data from 158 recipients.
  • - Results indicate that older age, greater social support, and certain health conditions correspond with higher PPWB levels, which are linked to improved quality of life and reduced symptoms of PTSD, anxiety, and depression.
  • - The researchers suggest that future studies should explore these associations over time to better understand how PPWB affects HSCT recovery and to develop targeted interventions for improving patient outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!